26,422 results match your criteria Diffuse Sclerosis


Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features.

RMD Open 2019 4;5(1):e000826. Epub 2019 Mar 4.

Rheumatology A Department, Universite Paris Descartes, Paris, France.

Background: Systemic sclerosis (SSc) is a severe, progressive multiorgan disease but to date, there are no established standardised international guidelines for follow-up of patients with SSc. The goal of this project was to develop an expert consensus for annual systematic investigations in patients with SSc to enhance their standard-of-care.

Material And Methods: The Delphi method was applied. Read More

View Article

Download full-text PDF

Source
http://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2018-00082
Publisher Site
http://dx.doi.org/10.1136/rmdopen-2018-000826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446182PMC
March 2019
1 Read

Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis.

Clin Transl Immunology 2019 6;8(4):e1045. Epub 2019 Apr 6.

Rheumatology Group Centre for Inflammatory Diseases School of Clinical Sciences at Monash Health Monash University Clayton VIC Australia.

Objectives: Systemic sclerosis (SSc) is an autoimmune disease characterised by fibrosis, vascular dysfunction and immune dysregulation. The pathogenesis of SSc remains poorly understood, although studies have indicated a role for the innate immune response.

Methods: Here, we measured serum interleukin (IL)-1α, IL-1β and IL-18 levels in 105 SSc patients and 47 healthy controls (HC) and analysed them with respect to multiple clinical parameters. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cti2.1045
Publisher Site
http://dx.doi.org/10.1002/cti2.1045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451750PMC
April 2019
2 Reads

Systemic Sclerosis is Linked to Psoriasis and May Impact on Patients' Survival: A Large Cohort Study.

J Clin Med 2019 Apr 16;8(4). Epub 2019 Apr 16.

Department of Medicine B and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 5265601, Israel.

Although skin manifestations are quite common in systemic sclerosis (SSc), a link between SSc and psoriasis (PsO) has been poorly investigated. We assessed the Clalit medical database in a cohort study to compare the prevalence of PsO between SSc-patients and SSc-free controls. We also evaluated the SSc-related autoantibodies' role in the co-existence of the two conditions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8040521DOI Listing

Role of autonomic dysfunction in the regulation of myocardial blood flow in systemic sclerosis evaluated by cardiac magnetic resonance.

Int J Rheum Dis 2019 Apr 15. Epub 2019 Apr 15.

Department of Clinical Medicine, Clinical Immunology Unit-Scleroderma Center, Sapienza University of Rome, Rome, Italy.

Aim: Autonomic dysfunction (AD) is an early feature of systemic sclerosis (SSc). A regular endothelial function is a prerequisite for normal response of the myocardial blood flow (MBF) to cold pressure test (CPT). The aim of the study was to evaluate the relation between MBF and AD at rest and after CPT in asymptomatic SSc patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.13569DOI Listing
April 2019
1 Read

Anti-IL-10 antibody in systemic lupus erythematosus.

Open Access Rheumatol 2019 26;11:61-65. Epub 2019 Mar 26.

Division of Rheumatology and Allergology, St. Marianna University School of Medicine, Kawasaki City, Kanagawa, Japan,

Purpose: IL-10 is a cytokine known to inhibit inflammatory cytokines. To determine its role in the pathogenesis of systemic lupus erythematosus (SLE), the presence of anti-IL-10 antibody is required to be examined. Although antibodies against cytokines are known to be present in SLE, no studies have determined the role of IL-10, particularly in Japanese patients. Read More

View Article

Download full-text PDF

Source
https://www.dovepress.com/anti-il-10-antibody-in-systemic-lu
Publisher Site
http://dx.doi.org/10.2147/OARRR.S191953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440452PMC
March 2019
2 Reads

Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis.

Arthritis Res Ther 2019 Apr 15;21(1):96. Epub 2019 Apr 15.

Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Objective: Systemic sclerosis (SSc) can lead to ischemic complications such as digital ulcers (DUs). The aim of the study was to find predictors of DUs by clinical and new imaging methods.

Patients And Methods: All 79 SSc patients included in the study received a clinical, colour Doppler ultrasound (CDUS), fluorescence optical imaging (FOI) and capillaroscopy examination at baseline, and their capacity to predict new DU development was analysed in 76 patients at 12 months follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1875-1DOI Listing

Recurring Posterior reversible encephalopathy syndrome in a patient with polymyositis/systemic sclerosis overlap syndrome triggered by scleroderma renal crisis.

Eur J Rheumatol 2019 Apr 9. Epub 2019 Apr 9.

Department of General Internal Medicine, Akashi Medical Center, Akashi, Japan.

In posterior reversible encephalopathy syndrome (PRES) triggered by scleroderma renal crisis (SRC), modulation and adherence in immunosuppressive therapy are key for avoiding recurrence, complications, and death. A patient with polymyositis (PM)/systemic sclerosis (SSc) overlap syndrome developed PRES triggered by SRC. To our knowledge, this is the first report of a case with PRES associated with PM/SSc overlap syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5152/eurjrheum.2019.18137DOI Listing
April 2019
1 Read

Purtscher's retinopathy in scleroderma.

GMS Ophthalmol Cases 2019 1;9:Doc07. Epub 2019 Mar 1.

Department of Internal Medicine, East Jeddah Hospital, Jeddah, Saudi Arabia.

We report a unique case of a 37-year-old patient, a known case of scleroderma, complaining of bilateral acute visual disturbance, which was diagnosed later on as Purtscher's retinopathy. After systemic assessment, she was diagnosed with bilateral kidney disease, consequently requiring further management accordingly. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3205/oc000096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436001PMC

[Very early and early systemic sclerosis: An update].

Rev Med Interne 2019 Apr 10. Epub 2019 Apr 10.

Service de médecine interne, hôpital Joseph Ducuing, 15 rue de Varsovie, 31076 Toulouse, France.

Classification criteria for systemic sclerosis evolved over the last three decades, allowing an earlier classification. In the late 2000s, the EULAR Scleroderma Trials and Research Group validated very early and early systemic sclerosis criteria. Raynaud phenomenon, anti-nuclear antibody positivity and the puffy fingers are "Red flags" that must lead to refer the patient to a specialist and benefit from a capillaroscopy and the specific autoantibodies. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02488663193042
Publisher Site
http://dx.doi.org/10.1016/j.revmed.2019.03.327DOI Listing
April 2019
2 Reads

Imaging calcinosis in patients with systemic sclerosis by radiography, computerised tomography and magnetic resonance imaging.

Semin Arthritis Rheum 2019 Mar 9. Epub 2019 Mar 9.

Centre for Musculoskeletal Research, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK.

Introduction: Objective outcome measures are needed to facilitate clinical trials of much needed treatments for calcinosis in systemic sclerosis (SSc). Our primary aim was to compare radiography, computed tomography (CT) and magnetic resonance imaging (MRI) to measure calcinotic lesions. Secondary objectives included to examine reproducibility of radiography and MRI, and inter-rater reliability of MRI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2019.03.001DOI Listing

Abnormalities in endothelial form of nitric oxide synthase is pathogenic in limited cutaneous systemic sclerosis.

J Cosmet Dermatol 2019 Apr 13. Epub 2019 Apr 13.

Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan, China.

Background: Limited cutaneous systemic sclerosis is one subtype of systemic sclerosis which is characterized by a prototypic multisystem fibrotic disorder.

Objective: This study aimed to further investigate the pathological mechanism of limited cutaneous systemic sclerosis (lcSSc).

Methods: The dataset GSE76807 generated from 10 lcSSc patients and five healthy controls was used. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocd.12917DOI Listing

Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports.

Transplant Proc 2019 Apr 9;51(3):865-870. Epub 2019 Jan 9.

Institute for Laboratory and Transfusion Medicine, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr University Bochum, Bad Oeynhausen, Germany.

Background: Although low (but increasing) rates of lung/lung-heart transplantations of scleroderma (systemic sclerosis [SSc]) patients have been reported, exclusive heart transplantation is a rare approach for treatment of heart failure due to SSc.

Cases: We report on 2 cases of SSc patients receiving a heart transplantation (HTx) due to severe and progressive right heart failure without pulmonary artery hypertension. One patient received a hepatitis C virus (HCV)-positive donor heart and recovered excellently from viral transmission after administration of a direct-acting antiviral (DAA) regimen. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2019.01.025DOI Listing
April 2019
1 Read

Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by C-PBR28 MR-PET.

Mult Scler 2019 Apr 11:1352458519843048. Epub 2019 Apr 11.

Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA.

Background: Activated microglia, which can be detected in vivo by C-PBR28 positron emission tomography (PET), represent a main component of MS pathology in the brain. Their role in the cerebellum is still unexplored, although cerebellar involvement in MS is frequent and accounts for disability progression.

Objectives: We aimed at characterizing cerebellar neuroinflammation in MS patients compared to healthy subjects by combining C-PBR28 MRI-Positron Emission Tomography (MR-PET) with 7 Tesla (T) MRI and assessing its relationship with brain neuroinflammation and clinical outcome measures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519843048DOI Listing
April 2019
2 Reads

Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis.

Arthritis Rheumatol 2019 Apr 10. Epub 2019 Apr 10.

Univ. Lille, U995 - LIRIC - Lille Inflammation Research International Center, F-59000, Lille, France.

Objectives: Systemic sclerosis (SSc) is a heterogeneous connective tissue disease. The usual subclassification divides patients into limited (lc) and diffuse cutaneous (dc) subsets relying on the skin extension but may not capture the entire variability of clinical phenotypes. The European Scleroderma Trials and Research (EUSTAR) database is a prospective cohort providing data from 137 European referral centers. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40906
Publisher Site
http://dx.doi.org/10.1002/art.40906DOI Listing
April 2019
4 Reads

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Ann Rheum Dis 2019 Apr 9. Epub 2019 Apr 9.

Rheumatology A Department, Cochin Hospital, APHP, Paris Descartes University, Paris, France.

Objective: To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice.

Methods: We performed a prospective study including patients with SSc from the European Scleroderma Trials and Research (EUSTAR) network treated with rituximab and matched with untreated patients with SSc. The main outcomes measures were adverse events, skin fibrosis improvement, lung fibrosis worsening and steroids use among propensity score-matched patients treated or not with rituximab. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214816DOI Listing
April 2019
1 Read
10.377 Impact Factor

An update on the central nervous system manifestations of neurofibromatosis type 1.

Acta Neuropathol 2019 Apr 8. Epub 2019 Apr 8.

Department of Pathology, Johns Hopkins University School of Medicine, Sheikh Zayed Tower, Room M2101, 1800 Orleans Street, Baltimore, MD, 21231, USA.

Neurofibromatosis 1 (NF1) is an autosomal dominant genetic disorder that presents with variable phenotypes as a result of mutations in the neurofibromatosis type 1 (NF1) gene and subsequently, abnormal function of the protein product, neurofibromin. Patients with NF1 are at increased risk for central nervous system (CNS) manifestations including structural, functional, and neoplastic disease. The mechanisms underlying the varied manifestations of NF1 are incompletely understood, but the loss of functional neurofibromin, resulting in sustained activation of the oncoprotein RAS, is responsible for tumorigenesis throughout the body, including the CNS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-019-02002-2DOI Listing
April 2019
1 Read

Use of red cell distribution width in a population at high risk for pulmonary hypertension.

Respir Med 2019 Apr 16;150:131-135. Epub 2019 Mar 16.

Comprehensive Pulmonary Hypertension Center-University Medical Center, New Orleans, LA, USA; Louisiana State University Health Sciences Center, Section of Pulmonary/Critical Care and Allergy/Immunology, New Orleans, LA, USA. Electronic address:

Background: Pulmonary hypertension (PH) often presents with non-specific symptoms making early diagnosis difficult. Red cell distribution width (RDW) is a parameter routinely reported on an automated complete blood cell count that has been associated with numerous disease states. The purpose of this study was to further evaluate RDW as a biomarker for PH in at-risk populations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461373PMC
April 2019
1 Read

The Role of Exosome in Autoimmune Connective Tissue Disease.

Ann Med 2019 Apr 9:1-15. Epub 2019 Apr 9.

a Departments of Dermatology , Peking Union Medical College Hospital, Chinese Academy of Medical Sciences , Beijing , China , 100730.

Exosomes have generated significant interest in the last few decades owing to their important roles in a diverse range of biological pathways. They are nano-sized lipid bilayer membrane vesicles of endosomal origin, and are produced by a vast number of cell types. They are released into the extracellular environment and are found in most biological fluids. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07853890.2019.1592215DOI Listing
April 2019
1 Read
3.886 Impact Factor

Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.

Rheumatol Int 2019 Apr 6. Epub 2019 Apr 6.

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, China.

This study aims to investigate the global public interest in rheumatoid arthritis by evaluating search term popularity changes of the disease over a decade. Google Trends was applied to retrieve search popularity scores for the term 'rheumatoid arthritis' between January 2004 and December 2017, utilizing the category of "health". Overall, relative searches volume for rheumatoid arthritis steadily decreased from January 2004 to December 2010, and then slowly rose from January 2011 to December 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-019-04297-6DOI Listing
April 2019
1 Read

Polyarteritis Nodosa Neurologic Manifestations.

Neurol Clin 2019 May 16;37(2):345-357. Epub 2019 Mar 16.

Vasculitides and Scleroderma, Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Université Paris Descartes, 27, rue Fg Saint-Jacques, Paris 75679 Cedex 14, France. Electronic address:

Polyarteritis nodosa (PAN) is a necrotizing vasculitis affecting medium-sized vessels whose main manifestations are weight loss, fever, peripheral neuropathy, renal, musculoskeletal, gastrointestinal tract and/or cutaneous involvement(s), hypertension and/or cardiac failure. Peripheral neuropathy is one of the most frequent and earliest symptoms, affecting 50% to 75% of PAN patients. Central nervous system involvement affects only 2% to 10% of PAN patients, often late during the disease course. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ncl.2019.01.007DOI Listing
May 2019
1 Read

Lymphatic Function in Autoimmune Diseases.

Front Immunol 2019 20;10:519. Epub 2019 Mar 20.

HSS Research Institute, Hospital for Special Surgery, New York, NY, United States.

Lymphatic vessels are critical for clearing fluid and inflammatory cells from inflamed tissues and also have roles in immune tolerance. Given the functional association of the lymphatics with the immune system, lymphatic dysfunction may contribute to the pathophysiology of rheumatic autoimmune diseases. Here we review the current understanding of the role of lymphatics in the autoimmune diseases rheumatoid arthritis, scleroderma, lupus, and dermatomyositis and consider the possibility that manual therapies such as massage and acupuncture may be useful in improving lymphatic function in autoimmune diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435962PMC
March 2019
2 Reads

Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets.

Clin Epigenetics 2019 Apr 4;11(1):58. Epub 2019 Apr 4.

Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.

Background: Systemic sclerosis (SSc) is a rare autoimmune fibrosing disease with an incompletely understood genetic and non-genetic etiology. Defining its etiology is important to allow the development of effective predictive, preventative, and therapeutic strategies. We conducted this epigenomic study to investigate the contributions of DNA methylation to the etiology of SSc while minimizing confounding due to genetic heterogeneity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-019-0652-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449959PMC
April 2019
3 Reads

Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.

Arthritis Res Ther 2019 Apr 3;21(1):86. Epub 2019 Apr 3.

University of Lille, U995 - LIRIC - Lille Inflammation Research International Center, F-59000, Lille, France.

Background: Data on survival and prognosis factors in incident cohorts are scarce in systemic sclerosis (SStc). To describe survival, standardized mortality ratio (SMR), and prognosis factors in systemic sclerosis (SSc), we analyzed a multicenter French cohort of incident patients and performed a systematic review of the literature and meta-analysis.

Methods: A multicenter, French cohort study was conducted between January 1, 2000, and December 31, 2013. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1867-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446383PMC

Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival.

Arthritis Res Ther 2019 Apr 2;21(1):85. Epub 2019 Apr 2.

Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA.

Background: Systemic sclerosis (SSc) is a female-predominant disease, characterized by excessive extracellular matrix deposition (ECM) with dermal and internal organ fibrosis. Considering the sex-based disparity in disease incidence, estradiol (E2), an estrogen form with pro-fibrotic effects, may play a role in SSc. We reported that post-menopausal women with diffuse cutaneous (dc)SSc have higher serum E2 levels compared to similar aged, healthy controls. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1870-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444502PMC
April 2019
1 Read

The role of nailfold videocapillaroscopy in patients with systemic sclerosis.

Immunol Med 2018 Sep 4;41(3):113-119. Epub 2018 Nov 4.

a The First Department of Internal Medicine , University of Occupational and Environmental Health , Fukuoka , Japan.

Systemic sclerosis (SSc) is a complex disease which consists of autoimmunity, fibrosis and vasculopathy. Most organ involvement in SSc patients is related to progressive fibrosis. Once fibrosis progresses, it becomes impossible to maintain a normal structure histologically. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/25785826.2018.1531189DOI Listing
September 2018
1 Read

Curling Cuticles of the Great Toenails: A Case Report of Eponychogryphosis.

Authors:
Philip R Cohen

Cureus 2019 Jan 25;11(1):e3959. Epub 2019 Jan 25.

Dermatology, San Diego Family Dermatology, San Diego, USA.

The cuticle, also referred to as the eponychium, creates a seal between the proximal nail fold and the nail plate. It is derived from both the ventral and dorsal portions of the proximal nail fold. In addition to its principle function as a barrier preventing allergens, irritants and pathogens from entering the nail cul-de-sac, the cuticle can play a role as a model for evaluating the etiology and management of diseases that affect capillary microcirculation, provide a source of solid tissue for genetic disorder studies, and aid in the evaluation of patients in whom the diagnoses of either systemic scleroderma or dermatomyositis is being entertained. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.3959DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433083PMC
January 2019
4 Reads

Scleroderma renal crisis (SRC): risk factors for an increasingly rare organ complication.

J Rheumatol 2019 Apr 1. Epub 2019 Apr 1.

From the Department of Dermatology and Venereology, University Hospital Cologne, Cologne, Germany; IMSIE, University of Cologne, Cologne, Germany; Department of Rheumatology, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Rheumatology, University Hospital Heidelberg, Heidelberg, Germany; Department of Dermatology and Venerology, University Hospital Muenster, Muenster, University Hospital Halle, Halle, Germany; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Oncology, Hematology, Immunology, Rheumatology, Pulmology), University Hospital Tuebingen, Tuebingen, Germany; Department for Internal Medicine, Rheumatology, Immunology and Nephrology, Asklepios Clinic Altona, Hamburg, Germany; Department of Rheumatology, University Hospital Wuerzburg, Wuerzburg, Germany; Department of Dermatology and Allergology, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Rheumatology, Krankenhaus St. Josef, Wuppertal, Germany; Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Dermatology, Medical University of Graz, Graz, Austria; Department of Dermatology and Venereology, Ruhr-University-Bochum, Bochum, Germany; Department of Rheumatology, University Medical Center-UKSH, Luebeck, Germany; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten-Herdecke, Germany; Department of Rheumatology, Johanniter-Krankenhaus im Flaeming Treuenbrietzen, Treuenbrietzen, Germany; Department of Rheumatology, Immanuel Krankenhaus Berlin-Buch, Berlin, Germany; University Medical Center Freiburg, Freiburg, Germany; Department of Rheumatology, Justus Liebig University Giessen, Kerckhoff Clinic, Bad Nauheim, Germany; Department of Dermatology, HELIOS University Hospital Wuppertal, Wuppertal, Germany; Department of Rheumatology, University Hospital Erlangen, Erlangen, Germany; Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany. This study was supported by a grant of the German Federal Ministry of Education and Research (BMBF) (01GM0310 NH, TK; 01GM0631 CS) and the Edith-Busch-Foundation. The work of Pia Moinzadeh was supported by a "Koeln Fortune" (155/2014) and "Deutsche Stiftung Sklerodermie" (3649/0096/31) grant. The first author (Pia Moinzadeh) and the last author (Nicolas Hunzelmann) received speaking fees from Actelion Pharmaceuticals and research grants from Actelion and Bayer Pharmaceuticals. But all authors declare no conflict of interest regarding this analysis. Address correspondence to Pia Moinzadeh, MD Department of Dermatology and Venereology, University of Cologne Kerpener Str. 62, 50937 Cologne, email:

Objective: Scleroderma renal crisis (SRC) is a severe life-threatening manifestation in patients with systemic sclerosis (SSc). However, the knowledge about risk factors for SRC is limited. We here determined the frequency of SRC and identified risk factors for the prediction of SRC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180582DOI Listing
April 2019
2 Reads

Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis.

Reumatismo 2019 Apr 1;71(1):19-23. Epub 2019 Apr 1.

Department of Rheumatology, University Hospital ASST-FBF-Sacco, Milano.

Klotho is a transmembrane and soluble glycoprotein that governs vascular integrity. Previous studies have demonstrated reduced serum klotho concentrations in patients with systemic sclerosis (SSc), and it is known that klotho deficiency can impair the healing of digital ulcers related to microvessel damage. The aim of this study was to evaluate the association between serum klotho levels and nailfold capillaroscopic abnormalities in SSc patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/reumatismo.2019.1129DOI Listing
April 2019
1 Read

Acquired Gitelman Syndrome Associated with Systemic Sclerosis.

Cureus 2019 Jan 20;11(1):e3923. Epub 2019 Jan 20.

Internal Medicine, Einstein Medical Center, Philadelphia, USA.

Gitelman syndrome is an inherited renal disorder characterized by hypomagnesemia, hypokalemia, hypocalciuria and metabolic alkalosis linked to the genes encoding the thiazide sensitive NaCl cotransporter (NCCT) located on the distal convoluted tubule of the kidney. It usually presents in late childhood or early adulthood with electrolyte abnormalities resembling chronic thiazide diuretic use. Acquired Gitelman syndrome is a very rare disorder mostly associated with Sjogren's syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.3923DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430306PMC
January 2019
4 Reads

[Clinical Pharmaceutical Research Based on New Proteome Analysis Based on Chromatographic Separation].

Authors:
Kaname Ohyama

Yakugaku Zasshi 2019 ;139(4):505-509

Graduate School of Biomedical Sciences, Nagasaki University.

Comprehensive identification of antigens in immune complexes (IC-antigens) is beneficial to provide insights into pathophysiology and could form the basis for novel diagnostic and treatment strategies for many immune-related diseases. Immune complexome analysis is a method for comprehensively identifying and profiling IC-antigens in biological fluids (such as serum and cerebrospinal fluid). We applied this strategy to the analysis of circulating ICs in autoimmune diseases (rheumatoid arthritis, Sjögren's syndrome, systemic scleroderma, and systemic lupus erythematosus), infectious diseases, and cancers. Read More

View Article

Download full-text PDF

Source
https://www.jstage.jst.go.jp/article/yakushi/139/4/139_18-00
Publisher Site
http://dx.doi.org/10.1248/yakushi.18-00167DOI Listing
April 2019
5 Reads

Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis.

Adv Ther 2019 Mar 30. Epub 2019 Mar 30.

University of Colorado School of Medicine, Denver, CO, USA.

Introduction: Interstitial lung disease (ILD) is a common manifestation of scleroderma/systemic sclerosis (SSc). However, the direct and indirect economic burdens of SSc-ILD remain unclear. This study assessed and compared healthcare resource utilization (HRU), direct healthcare costs, work loss, and indirect costs between patients with SSc-ILD and matched controls with neither SSc nor ILD in the USA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-019-00929-2DOI Listing
March 2019
5 Reads

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.

Ann Rheum Dis 2019 Mar 30. Epub 2019 Mar 30.

Department of Medicine, University of Melbourne at St. Vincent Hospital, Melbourne, Fitzroy, Victoria, Australia

Objective: We sought to develop the first Damage Index (DI) in systemic sclerosis (SSc).

Methods: The conceptual definition of 'damage' in SSc was determined through consensus by a working group of the Scleroderma Clinical Trials Consortium (SCTC). Systematic literature review and consultation with patient partners and non-rheumatologist experts produced a list of potential items for inclusion in the DI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214764DOI Listing
March 2019
1 Read
10.377 Impact Factor

Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Hum Brain Mapp 2019 Mar 28. Epub 2019 Mar 28.

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

The extent of central nervous system involvement in Kennedy's disease (KD) relative to other motor neuron disease (MND) phenotypes still needs to be clarified. In this study, we investigated cortical and white matter (WM) MRI alterations in 25 patients with KD, compared with 24 healthy subjects, 25 patients with sporadic amyotrophic lateral sclerosis (ALS), and 35 cases with lower motor neuron-predominant disease (LMND). LMND patients were clinically differentiated into 24 fast and 11 slow progressors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hbm.24583DOI Listing
March 2019
1 Read

Mönckeberg's arteriosclerosis: a possible reason for non-use of radial conduit.

Asian Cardiovasc Thorac Ann 2019 Mar 28:218492319841977. Epub 2019 Mar 28.

1 Department of Cardiology, Gaziosmanpasa Hospital, Faculty of Medicine, Istanbul Yeni Yuzyil University, Istanbul, Turkey.

We report the case of a 73-year-old man with diffuse calcification in both upper and lower limb arteries. This condition, termed Mönckeberg's arteriosclerosis, was accompanied by three-vessel disease needing coronary artery bypass grafting. The diagnosis of arteriosclerosis was further verified by histopathology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0218492319841977DOI Listing

Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature.

Medicine (Baltimore) 2019 Mar;98(13):e15052

Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, Azienda Ospedaliera Universitaria Senese.

Rationale: Aromatase inhibitors (AIs) are a class of drugs widely used in the treatment of estrogen sensitive breast and ovarian cancer which convert testosterone to estradiol and androstenedione to estrogen. The AIs of third generation, including anastrazole, letrozole and exemestane, have actually become the standard of care of estrogen-receptor-positive breast cancer in menopausal women and are recommended as adjuvant treatment after surgery in place of/or following tamoxifen. Their main side-effects include reduction in bone mineral density, occurrence of menopausal manifestations and development of musculoskeletal symptoms which are, usually, transient, but sometimes evolve into a typical form of arthritis, such as rheumatoid arthritis (RA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000015052DOI Listing
March 2019
1 Read

Autoantibodies are present before the clinical diagnosis of systemic sclerosis.

PLoS One 2019 26;14(3):e0214202. Epub 2019 Mar 26.

Nephrology Department, Walter Reed National Military Medical Center, Bethesda, MD, United States of America.

Systemic sclerosis (SSc) is a heterogeneous autoimmune disorder associated with vascular dysfunction and fibrotic changes in the skin, vasculature and internal organs. Although serologic abnormalities are an important diagnostic tool for SSc, little is known about whether autoantibodies precede clinical diagnosis. Here we investigated the presence of autoantibodies before SSc diagnosis and assessed whether certain autoantibodies might associate with the future onset of scleroderma renal crisis (SRC), a potentially fatal complication of the disease. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214202PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435159PMC

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

J Scleroderma Relat Disord 2019 Feb 18;4(1):17-27. Epub 2018 Jul 18.

Rheumatology Unit, University Hospital of Cagliari.

The Scleroderma Clinical Trials Consortium (SCTC) represents many of the clinical researchers in the world who are interested in improving the efficiency of clinical trials in Systemic Sclerosis (SSc). The SCTC has established 11 working groups (WGs) to develop and validate better ways of measuring and recording multiple aspects of this heterogeneous disease. These include groups working on arthritis, disease damage, disease activity, cardiac disease, juvenile SSc, the gastrointestinal tract, vascular component, calcinosis, scleroderma renal crisis, interstitial lung disease, and skin measurement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2397198318783926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428445PMC
February 2019
1 Read

Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: A preliminary cross-sectional study.

Mult Scler Relat Disord 2019 Mar 12;31:22-31. Epub 2019 Mar 12.

Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address:

Background: Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is a rare autosomal-dominant white matter disease, typically characterized by juvenile cognitive decline and frontoparietal white matter lesions. A portion of HDLS patients exhibit preferential motor dysfunctions as their initial symptoms, mimicking multiple sclerosis (MS). However, there is no study comparing this phenotype of HDLS and primary progressive multiple sclerosis (PPMS), which greatly resemble each other. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.03.008DOI Listing
March 2019
2 Reads

A Prospective Pilot Study of Vascular Assessment of the Upper Extremity With Laser Angiography.

Hand (N Y) 2019 Mar 21:1558944719837023. Epub 2019 Mar 21.

1 The Curtis National Hand Center, MedStar Union Memorial Hospital, Baltimore, MD, USA.

Background: Our goal was to investigate patients' upper extremity tissue perfusion changes using an indocyanine green laser angiography imaging system for various pathologic states and interventions.

Methods: This prospective observational study used Spy Elite/LUNA laser angiography to evaluate perfusion in patients with upper extremity vascular compromise. All patients had Spy Elite/LUNA imaging as well as clinical and handheld Doppler examinations preintervention, intraoperatively, if applicable, and at 1 week, 2 weeks, and 2 months postintervention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1558944719837023DOI Listing
March 2019
2 Reads

Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.

J Dermatolog Treat 2019 Mar 20:1-8. Epub 2019 Mar 20.

a Pharmerit International LP , Bethesda , MA , USA.

Introduction: The National Comprehensive Cancer Network and the European Organization for Research and Treatment of Cancer recommend extracorporeal photopheresis (ECP) as systemic therapy for cutaneous T-cell lymphoma (CTCL).

Objective: To investigate real-world use of ECP in CTCL patients in the US.

Methods: Data from the Truven MarketScan database (2010-2015) were used to create a cohort of CTCL patients receiving systemic treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2019.1587144DOI Listing
March 2019
3 Reads

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.

Front Immunol 2019 27;10:337. Epub 2019 Feb 27.

Division of Biodiagnostic Sciences and Technologies, INRASTES, National Center for Scientific Research Demokritos, Athens, Greece.

Thrombotic microangiopathies (TMAs) are a heterogeneous group of syndromes presenting with a distinct clinical triad: microangiopathic hemolytic anemia, thrombocytopenia, and organ damage. We currently recognize two major entities with distinct pathophysiology: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Beyond them, differential diagnosis also includes TMAs associated with underlying conditions, such as drugs, malignancy, infections, scleroderma-associated renal crisis, systemic lupus erythematosus (SLE), malignant hypertension, transplantation, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets), and disseminated intravascular coagulation (DIC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413705PMC
February 2019
2 Reads

Scleroderma renal crisis with coexisting segmental arterial mediolysis presenting as intraperitoneal bleeding: a case report.

J Med Case Rep 2019 Mar 20;13(1):74. Epub 2019 Mar 20.

Department of Rheumatology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.

Background: Segmental arterial mediolysis is a rare nonarteriosclerotic and noninflammatory vascular disease that may cause intraperitoneal bleeding. Scleroderma renal crisis is a rare complication of systemic sclerosis, leading to severe hypertension and renal dysfunction. To the best of our knowledge, this is the first reported case of a patient with concurrent systemic sclerosis with scleroderma renal crisis and pathologically confirmed segmental arterial mediolysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13256-019-1993-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425683PMC
March 2019
1 Read

Scleroderma patients with antibodies against the large subunits of both RNA polymerases-I and -III are protected against cancer.

Arthritis Rheumatol 2019 Mar 19. Epub 2019 Mar 19.

Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, USA.

Objectives: While compelling data suggest a cancer-induced autoimmunity model in scleroderma patients with anti-RNA polymerase III large subunit (anti-RPC155) antibodies, ~85% of these patients do not manifest cancer. We hypothesized that anti-RPC155-positive scleroderma patients without detectable cancer target additional autoantigens.

Methods: 168 scleroderma patients with anti-RPC155 antibodies were studied: 80 with a cancer history, and 88 with no cancer diagnosis after >5 years of follow-up. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40893
Publisher Site
http://dx.doi.org/10.1002/art.40893DOI Listing
March 2019
2 Reads

Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study.

BMC Rheumatol 2018 7;2:36. Epub 2018 Dec 7.

5Department of Cardiology, Herlev and Gentofte Hospital, Gentofte, Kildegårdsvej 28, 2900 Hellerup, Denmark.

Background: To investigate the incidence and the mortality-rates of systemic sclerosis (SSc), its primary causes of death, and the temporal trends in events in Denmark during the last decades.

Methods: Using the Danish National Patient Registry, we identified all persons aged ≥18 years with a first-time diagnosis of SSc (ICD-10 code M34, excluding M34.2) between 1995 and 2015. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41927-018-0043-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390621PMC
December 2018

A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis.

BMC Rheumatol 2018 15;2:13. Epub 2018 May 15.

1Hospital of the University of Pennsylvania, Philadelphia, USA.

Background: Systemic Sclerosis is a multifactorial autoimmune rheumatic disease characterized by inflammation, fibrosis, immune dysregulation and vascular dysfunction.

Methods: An open label, prospective, non-comparative study evaluating ambrisentan with an antifibrotic agent in diffuse cutaneous systemic sclerosis (dcSSc). Recruited 15 consecutive patients with dcSSc who were already on a stable dose of an antifibrotic agent and if they met inclusion criteria they were initiated on ambrisentan 5 mg/day for 12 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41927-018-0021-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390567PMC
May 2018
1 Read

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.

RMD Open 2018 26;4(Suppl 1):e000786. Epub 2019 Feb 26.

Referral Center for Systemic Autoimmue Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.

The term 'undifferentiated connective tissue disease' (UCTD) is generally used to describe clinical entities characterised by clinical and serological manifestations of systemic autoimmune diseases but not fulfilling the criteria for defined connective tissue diseases (CTDs). In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the ERN ReCONNET project, aimed at evaluating existing clinical practice guidelines (CPGs) or recommendations. No specific CPG on UCTD were found, potential areas of intervention are absence of a consensus definition of UCTD, need for specific monitoring and therapeutic protocols, stratification of UCTD based on the risk of developing a defined CTD and preventive measure for the future development of a more severe condition. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2018-000786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397427PMC
February 2019
7 Reads

Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines.

RMD Open 2018 26;4(Suppl 1):e000784. Epub 2019 Feb 26.

Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

Idiopathic inflammatory myopathies (IIMs) encompass a heterogeneous group of rare autoimmune diseases characterised by muscle weakness and inflammation, but in antisynthetase syndrome arthritis and interstitial lung disease are more frequent and often inaugurate the disease. Clinical practice guidelines (CPGs) have been proposed for IIMs, but they are sparse and heterogeneous. This work aimed at identifying: i) current available CPGs for IIMs, ii) patients ' and clinicians' unmet needs not covered by CPGs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2018-000784DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397434PMC
February 2019
2 Reads

Atypical Presentation of Acute Disseminated Encephalomyelitis (ADEM) in a Middle-Aged Adult.

Am J Case Rep 2019 Mar 19;20:361-365. Epub 2019 Mar 19.

Department of Internal Medicine, Texas Tech University Health Science Center at the Permian Basin, Odessa, TX, USA.

BACKGROUND Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease that usually presents in pediatric patients, usually following a viral or bacterial infection. The clinical findings in ADEM include acute neurologic decline that typically presents with encephalopathy, with some cases progressing to multiple sclerosis. An atypical case of ADEM is reported that presented in a middle-aged adult. Read More

View Article

Download full-text PDF

Source
https://www.amjcaserep.com/abstract/index/idArt/911397
Publisher Site
http://dx.doi.org/10.12659/AJCR.911397DOI Listing
March 2019
10 Reads

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.

Neurol Neuroimmunol Neuroinflamm 2019 May 7;6(3):e541. Epub 2019 Mar 7.

Neurologic Clinic and Policlinic (B.P., T.J.D., T.S.), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland; NeuroCure Clinical Research Center (N.B., L.R., J.B.-S., F.P., T.S.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Department of Neurology (N.B., J.B.-S., K.R., F.P.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Experimental and Clinical Research Center (F.P.), Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine; Clinical and Experimental Multiple Sclerosis Research Center (K.R., F.P.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Berlin Ultrahigh Field Facility (T.N.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Germany; Medical Image Analysis Center AG (J.W., T.S.); and qbig (J.W.), Department of Biomedical Engineering, University of Basel, Basel, Switzerland.

Objective: To investigate and compare occult damages in aquaporin-4 (AQP4)-rich periependymal regions in patients with neuromyelitis optica spectrum disorder (NMOSD) vs healthy controls (HCs) and patients with multiple sclerosis (MS) applying quantitative T1 mapping at 7 Tesla (T) in a cross-sectional study.

Methods: Eleven patients with NMOSD (median Expanded Disability Status Scale [EDSS] score 3.5, disease duration 9. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410932PMC
May 2019
2 Reads

Cognitive functions and social cognition in multiple sclerosis: An overview.

Hell J Nucl Med 2019 Jan-Apr;22 Suppl:102-110

1st Department of Psychiatry, Aristotle University of Thessaloniki, "Papageorgiou" General Hospital, Thessaloniki, Greece.

Cognitive decline has been widely reported in patients with multiple sclerosis (MS) despite its clinical heterogeneity, at all stages and in all subtypes of the disease. Deficits are most commonly present in attention, processing speed, working memory, verbal fluency and executive function. However, MS patients also show decreased performance in tasks related to social cognition, i. Read More

View Article

Download full-text PDF

Source
January 2019